Clinical Trial Update: Thalidomide Therapy for VEOIBD

View source ↗

Summary

A clinical trial is evaluating thalidomide therapy for very early onset inflammatory bowel disease (VEOIBD); recruitment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Very Early Onset Inflammatory Bowel Disease

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Inflammatory Bowel Diseases | Status: RECRUITING